Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trial (Q39563089)

From Wikidata
Jump to navigation Jump to search
scientific article published on 6 April 2011
edit
Language Label Description Also known as
English
Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trial
scientific article published on 6 April 2011

    Statements

    Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trial (English)
    Annie-Claire Diserens
    Mathilde C M Kouwenhoven
    Mauro Delorenzi
    Marie-France Hamou
    Matthias S Matter
    Frank L Heppner
    Yasuhiro Yonekawa

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit